Skip to evidence report

ASPC.adipocyte_capillary_interface: Studies — page 4

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 1,040 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 3,001–4,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for ASPC.adipocyte_capillary_interface
#Trait / studyIndividual trait IDMean IC score
3001Kidney volumeGCST900166701.32
3002EmphysemaFING000004961.32
3003KDR levelsGCST904696721.32
3004Abdominal fat ratioGCST902673601.32
3005Free Cholesterol to Total Lipids in Large HDL percentageGCST904977931.32
3006Left-hemisphere dorsal attention network to right-hemisphere salience/ventral attention network white-matter structural connectivityGCST903026971.32
3007Triglycerides in chylomicrons and extremely large VLDL (UKB data field 23487)GCST902695841.32
3008IGFBP3 levelsGCST904695291.32
3009CTSL levelsGCST900120731.31
3010Ever had period extreme irritability | ManiaUKBB000002171.31
3011CTSZ/SMPDL3A ratioGCST903143221.31
3012Cholesteryl esters to total lipids in very large VLDL percentage (UKB data field 23586)GCST902696831.31
3013IDP dMRI ProbtrackX MD str lGCST900042421.31
3014Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T493ECGA0004931.31
3015Bone marrow fat fraction of lumbar vertebra 2GCST906523871.31
3016IDP SWI T2star left caudateGCST900038651.31
3017Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T431ECGA0004311.31
3018Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T150ECGU0001501.31
3019Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T58ECGU0000581.31
3020Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T250ECGU0002501.31
3021wg rh intensity-contrast fusiformGCST900038331.31
3022Free cholesterol in HDL (UKB data field 23422)GCST902695191.31
3023JAM2/TNFRSF21 ratioGCST903152421.31
3024Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T40ECGA0000401.31
3025PCDHB15 levelsGCST904701731.31
3026GLOD4 levelsGCST904693591.31
3027YARS1 levelsGCST904710871.31
3028Lung adenocarcinomaGCST0047441.31
3029Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST905021531.31
3030Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T497ECGA0004971.30
3031Triglycerides in VLDL (UKB data field 23408)GCST902695051.30
3032DAPK2 levelsGCST904689451.30
3033AKR7L levelsGCST904682751.30
3034SERPINF1 levelsGCST904705981.30
3035ADGRE2/IFNGR1 ratioGCST903131771.30
3036Saturated fatty acids levelsGCST905026711.30
3037PAPL levelsGCST904272081.30
3038Bariatric surgery (PheCode 539)GCST904760551.30
3039JAM2 levelsGCST904696591.30
3040ERBB2 levelsGCST904691391.30
3041Aspartate aminotransferase (AST, mean, inv-norm transformed)GCST904751211.30
3042Hypertrophy of breast (Gynecomastia) (PheCode 612.2)GCST904761631.30
3043Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T50ECGA0000501.30
3044aparc-a2009s lh area S-temporal-supGCST900033691.30
3045aparc-a2009s rh volume S-collat-transv-antGCST900030481.29
3046NTPROBNP levelsGCST904700961.29
3047AmygNuclei rh volume Cortical-nucleusGCST900026641.29
3048CDH5/TEK ratioGCST903139611.29
3049ACVRL1/EFNA4 ratioGCST903131561.29
3050TSC22D1 levelsGCST904709731.29
3051IDP dMRI ProbtrackX L2 atr rGCST900042761.29
3052DOK2 levelsGCST904690291.29
3053Triglycerides in small HDLGCST904995161.29
3054SFRP1 levelsGCST904706101.29
3055IDP dMRI TBSS ICVF Posterior thalamic radiation RGCST900043551.29
3056NRCAM/NTRK2 ratioGCST903155521.29
3057Concentration of chylomicrons and extremely large VLDL particlesGCST905010101.29
3058CIAPIN1/SNX9 ratioGCST903140681.29
3059Docosahexaenoic acid levelsGCST904972561.29
3060HippSubfield rh volume CA1-bodyGCST900026921.29
3061Moderate visual impairment, binocularFING000008311.29
3062LAT/LYN ratioGCST903152831.29
3063Phospholipids in large HDLGCST904978531.28
3064triglyceride (mean, inv-norm transformed)GCST904764331.28
3065APOB/APOA1 ratioGCST904971581.28
3066Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905010921.28
3067FEV1GCST0074321.28
3068ACY1/GSTA1 ratioGCST903131631.28
3069GOPC levelsGCST904693771.28
3070Lung function (FVC)GCST900259981.28
3071Phosphatidylcholine_34:0_[M+H]1+/Phosphatidylethanolamine_37:0_[M+H]1+/Phosphatidate_39:1_[M+NH4]1+ levelsGCST900603111.28
3072Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905009561.28
3073Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T312ECGU0003121.28
3074PLXNA4 levelsGCST904702651.28
3075PROC levelsGCST904703351.28
3076Operation code - spine or back surgery | OperationsUKBB000005651.28
3077Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T313ECGU0003131.28
3078Ganglion cell inner plexiform layer (GCIPL) thicknessGCST900142671.28
3079IDP dMRI ProbtrackX L2 slf rGCST900042951.28
3080Polyunsaturated fatty acids to total fatty acids percentageGCST905026321.28
3081CPXM1/LGMN ratioGCST903142201.28
3082Cholesterol esters in very small VLDLGCST905007491.28
3083Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T187ECGU0001871.28
3084Other joint disordersFING000010641.28
3085Operation code - spinal laminectomy | OperationsUKBB000005641.28
3086Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905009291.27
3087DGKA levelsGCST904689891.27
3088VPS37A levelsGCST904710461.27
3089VASN levelsGCST904710271.27
3090aparc-DKTatlas rh volume cuneusGCST900028961.27
3091SYTL4 levelsGCST904707951.27
3092BCL2L1 levelsGCST904684321.27
3093Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T153ECGA0001531.27
3094IDP T1 FAST ROIs L occ poleGCST900025451.27
3095Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T480ECGU0004801.27
3096CX3CL1 levelsGCST904689211.27
3097IDP dMRI ProbtrackX MO atr rGCST900040031.27
3098Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T319ECGU0003191.27
3099GALNT10/IGSF3 ratioGCST903149141.27
3100IDP dMRI TBSS FA Cerebral peduncle RGCST900038911.27
3101CA1/CA2 ratioGCST903135711.27
3102CACYBP levelsGCST904685241.27
3103DCBLD2 levelsGCST904689521.27
3104APOA1 levelsGCST904683311.27
3105aseg global volume BrainSegNotVentGCST900025911.27
3106Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T313ECGA0003131.27
3107Substance dependenceGCST900187041.27
3108Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T485ECGU0004851.27
3109Brain age gapGCST905580341.27
3110F11R levelsGCST904691641.27
3111Total lipid levels in chylomicrons and extremely large VLDLGCST905010021.27
3112NCAM1 levelsGCST904700031.26
3113COMP levelsGCST904688271.26
3114DCTN1/FXN ratioGCST903144301.26
3115CD8 on Effector Memory CD8+ T cellGCST900020561.26
3116Medication use (diuretics)GCST900187651.26
3117X-12095--N1-methyl-3-pyridone-4-carboxamide levelsGCST902437011.26
3118Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T111ECGU0001111.26
3119DTI autoptx FA unc l tractGCST903851371.26
3120Job involves shift work | EmploymentUKBB000003851.26
3121Free cholesterol in very large VLDL (UKB data field 23493)GCST902695901.26
3122ALCAM/IL1RL2 ratioGCST903132381.26
3123Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T492ECGA0004921.26
3124Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T235ECGU0002351.26
3125IMPACT levelsGCST904696111.26
3126T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 2)GCST903205651.26
3127aseg global volume SupraTentorialGCST900025951.26
3128HippSubfield rh volume subiculum-bodyGCST900026911.25
3129TPPP3 levelsGCST904709481.25
3130Aneurysms, operations, SAHFING000000851.25
3131IDP dMRI TBSS L2 Posterior thalamic radiation RGCST900041511.25
3132Small cell lung carcinomaGCST0047461.25
3133ERBIN levelsGCST904691421.25
3134SMOC2 levelsGCST904227731.25
3135Other strabismusFING000011141.25
3136CTSH levelsGCST904689131.25
3137QC T1-to-standard linear alignment discrepancyGCST900063451.25
3138Fruit intake (weighted GWA)GCST902672831.25
3139PHACTR2 levelsGCST904702241.25
3140JAM3 levelsGCST904696601.25
3141Asthma with exacerbation (PheCode 495.2)GCST904760251.25
3142DAAM1 levelsGCST904689411.25
3143LRP1 levelsGCST904697971.24
3144Athlete's foot (PheCode 110.12)GCST904755631.24
3145Lysoalkenylphosphatidylethanolamine (P-20:0) levelsGCST900254601.24
3146Free Cholesterol to Total Lipids in Very Large VLDL percentageGCST905005931.24
3147Membranous nephropathyGCST0100061.24
3148NCR3LG1 levelsGCST904700101.24
3149Phosphatidylcholine (40:8) levelsGCST900255381.24
3150Saturated fatty acids to total fatty acids percentageGCST905026961.24
3151Principal component-derived dietary pattern 5GCST901330101.24
3152Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T298ECGU0002981.24
3153IDP dMRI TBSS L3 Superior corona radiata LGCST900041961.24
3154Alkenylphosphatidylcholine (P-16:0/16:0) levelsGCST900255631.24
3155N-formylanthranilic acid levelsGCST901999601.24
3156Malignant neoplasm of female breast | neoplasmsUKBB000004261.24
3157Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905010451.23
3158Percentage of M9 (GP18)GCST906684621.23
3159EIF4B levelsGCST904690941.23
3160FLRT2/GFRA3 ratioGCST903148551.23
3161CLIP2 levelsGCST904687821.23
3162DTI TBSS L2 Cingulum hippocampus LGCST903845131.23
3163COMP/ITGAV ratioGCST903141901.23
3164FCRL2/KLB ratioGCST903147981.23
3165Cardiac defibrillator in situ (PheCode 426.92)GCST904759611.23
3166Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T69ECGU0000691.23
3167Atrial fibrillation and flutter with reimbursementFING000001271.23
3168IDP dMRI TBSS MO Medial lemniscus RGCST900039601.23
3169CNDP1 levelsGCST904687961.23
3170DTYMK levelsGCST904690491.23
3171Triglycerides in large VLDL (UKB data field 23501)GCST902695981.23
3172GRN levelsGCST904694041.23
3173aparc-DKTatlas lh volume caudalanteriorcingulateGCST900028631.23
3174IDP dMRI TBSS MO Middle cerebellar peduncleGCST900039521.23
3175BA-exvivo rh area perirhinalGCST900032331.22
3176PDGFB levelsGCST900120161.22
3177Right-hemisphere somatomotor network to hippocampus white-matter structural connectivityGCST903027981.22
3178Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T154ECGA0001541.22
3179Hippocampal subfield left CA4 volume (head)GCST902679431.22
3180IST1 levelsGCST904696321.22
3181Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T70ECGU0000701.22
3182FAM151A levelsGCST902424501.22
3183DTI autoptx FA atr r tractGCST903851151.22
3184CD46/TNFRSF14 ratioGCST903138381.22
3185Total lipids in large HDLGCST904978151.22
3186SLC51B levelsGCST904706641.22
3187GHR levelsGCST904693421.22
3188ERBB2/FURIN ratioGCST903146861.22
3189Gastro-oesophageal reflux diseaseFING000005641.22
3190DPP10 levelsGCST904690321.21
3191FVCGCST902786291.21
3192Chronic bronchitis (PheCode 496.2)GCST904760291.21
3193Alzheimer's disease (MTAG)GCST904490621.21
3194MyopiaFING000008531.21
3195EDIL3 levelsGCST904690721.21
3196Left-hemisphere default mode network to right-hemisphere default mode network white-matter structural connectivityGCST903027661.21
3197Plasma 3-hydroxybutyroylglycine** levels in chronic kidney diseaseGCST902644881.21
3198Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T85ECGA0000851.21
3199IDP dMRI TBSS L2 Anterior corona radiata LGCST900041461.21
3200FKBP1B/TGFB1 ratioGCST903148361.21
3201DTI TBSS FA Superior longitudinal fasciculus RGCST903844201.21
3202GPNMB levelsGCST904693931.21
3203Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T113ECGU0001131.21
3204ENG/NCAM2 ratioGCST903146471.21
3205MFAP5 levelsGCST904698991.21
3206Cholesteryl Esters in HDLGCST904973681.21
3207IDP dMRI TBSS MD Anterior corona radiata LGCST900040501.21
3208SIRT2 levelsGCST904706421.21
3209Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T198ECGA0001981.20
3210Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T14ECGA0000141.20
3211FGFBP2 levelsGCST904692311.20
3212Calcium levelsGCST900259901.20
32131-palmitoyl-2-stearoyl-gpc (16:0/18:0) levelsGCST902000411.20
3214MESD/SNX9 ratioGCST903154231.20
3215CCL11/CCL2 ratioGCST903136721.20
3216Psoriatic arthropathiesFING000012251.20
3217VWA1 levelsGCST904710611.20
3218Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T197ECGA0001971.20
3219PLIN3 levelsGCST904702591.20
3220MESD levelsGCST904698911.20
3221Valine levelsGCST905001761.20
3222Concentration of large VLDL particles (UKB data field 23495)GCST902695921.20
3223DKK4/REG1B ratioGCST903144901.20
3224Triglycerides in very large VLDLGCST905006801.20
3225PCDH7 levelsGCST904701711.20
3226PLAUR/TREM2 ratioGCST903156761.20
3227CRADD/EREG ratioGCST903142361.20
3228DTI TBSS L2 Uncinate fasciculus RGCST903845201.20
3229CD69/CEP43 ratioGCST903138671.20
3230Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T482ECGU0004821.20
3231N-acetyl-1-methylhistidine levelsGCST902006901.20
3232Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T69ECGA0000691.19
3233Prescriptions - gliclazide | sulfonylurea,diabetesUKBB000006841.19
3234IDP T1 FAST ROIs L hippocampusGCST900025551.19
3235DKK4 levelsGCST904689991.19
3236ALB levelsGCST902786161.19
3237Triacylglycerol_53:4_[M+NH4]1+ levelsGCST900605241.19
3238DMP1 levelsGCST904690071.19
3239IDP dMRI ProbtrackX FA slf lGCST900039461.19
3240LGALS8/SOD2 ratioGCST903153201.19
3241Total lipid levels in large HDLGCST900928501.19
3242Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T327ECGA0003271.19
3243Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T325ECGA0003251.19
3244SCAMP3/STX4 ratioGCST903158051.19
3245acne vulgarisGCST902458181.19
3246IDP dMRI TBSS L1 Posterior corona radiata RGCST900041011.19
3247CD22/CD79B ratioGCST903137551.19
3248Free cholesterol in large VLDL (UKB data field 23500)GCST902695971.18
3249Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classifiedFING000004311.18
3250Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905020691.18
3251NSFL1C/PSMG3 ratioGCST903155591.18
3252Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T432ECGA0004321.18
3253Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T103ECGU0001031.18
3254Lysoalkylphosphatidylcholine (O-24:1) levelsGCST900241981.18
3255DSG3/DSG4 ratioGCST903145581.18
3256Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T387ECGA0003871.18
3257Other and unspecified polyneuropathies, also in other diseasesFING000009481.18
3258Phospholipid levels in chylomicrons and extremely large VLDLGCST905010421.18
3259aseg lh intensity VentralDCGCST900037751.18
3260Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905020751.18
3261aparc-DKTatlas rh area parstriangularisGCST900032831.17
3262MAP4K5 levelsGCST904698551.17
3263FXYD5 levelsGCST904692831.17
3264Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T111ECGA0001111.17
3265MAVS levelsGCST904698661.17
3266Chronic ulcer of skin (PheCode 707)GCST904762161.17
3267Nonalcoholic fatty liver diseaseFING000008781.17
3268Right ventricular ejection fractionGCST901345911.17
3269PRKAR1A levelsGCST904703261.17
3270Ceramide (d18:2/24:1) levelsGCST900246841.17
3271PDE5A levelsGCST904701871.17
3272SCAMP3 levelsGCST904705321.17
3273LAT/MANF ratioGCST903152841.17
3274Cholesterol to Total Lipids in Very Large VLDL percentageGCST905005391.17
3275Haematocrit percentage (UKB data field 30030)GCST904680731.17
3276IDP dMRI ProbtrackX FA cst lGCST900039331.17
3277Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T64ECGA0000641.17
3278LAT levelsGCST904697411.17
3279OTUD6B levelsGCST904701361.16
3280aparc-DKTatlas lh area supramarginalGCST900032631.16
3281Total Lipids in HDLGCST904973931.16
3282Birth weightGCST0075571.16
3283Phospholipids to Total Lipids in Large VLDL percentageGCST904982581.16
3284LTBP3 levelsGCST904698151.16
3285Total lipids in large VLDL (UKB data field 23496)GCST902695931.16
3286Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T326ECGU0003261.16
3287BA-exvivo rh area entorhinalGCST900032341.16
3288COL5A1 levelsGCST904688201.16
3289Left-hemisphere default mode network to right-hemisphere somatomotor network white-matter structural connectivityGCST903027611.16
3290TNFAIP2 levelsGCST904708961.16
3291TMSB10/TRIAP1 ratioGCST903159241.16
3292Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T433ECGA0004331.16
3293PPP1R9B levelsGCST904703051.15
3294NTN1 levelsGCST902420471.15
3295LIFR levelsGCST904697691.15
3296IDP dMRI TBSS L3 Middle cerebellar peduncleGCST900041711.15
3297CD58 levelsGCST904686381.15
3298HDL cholesterol levelsGCST904973521.15
3299Systolic blood pressure (BMI unadjusted)GCST903351621.15
3300Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T80ECGU0000801.15
3301T1 FreeSurfer a2009s rh S collat transv ant areaGCST903849391.15
3302Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T434ECGA0004341.15
3303Valine levels (UKB data field 23467)GCST902695641.15
3304TNFRSF10A levelsGCST904708991.15
3305SPINT1 levelsGCST902417171.15
3306Osteochondrodysplasia with defects of growth of tubular bones and spineFING000009101.15
3307TARBP2 levelsGCST904708051.15
3308IDP dMRI ProbtrackX L3 cgc rGCST900043051.15
3309Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T115ECGA0001151.15
3310HYOU1/ROR1 ratioGCST903151041.15
3311Malignant neoplasm of breast | Malignant neoplasm of breastUKBB000004241.15
3312Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T77ECGU0000771.15
3313ICD10 C53: Malignant neoplasm of cervix uteriGCST904542021.15
3314SHBG levelsUKBB000007671.15
3315Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T5ECGA0000051.15
3316ROBO2/SFTPD ratioGCST903157851.15
3317T1 FreeSurfer BA rh BA4p exvivo areaGCST903855521.15
3318TNFSF14 levelsGCST904709221.15
3319ATXN10 levelsGCST904684011.15
3320Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T73ECGU0000731.15
3321Right ventricular ejection fraction (MTAG)GCST901345951.15
3322IGSF9 levelsGCST904695411.14
3323Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T252ECGU0002521.14
3324Birth size (multivariate analysis)GCST906241011.14
3325S100A14 levelsGCST904705151.14
3326Vascular/heart problems diagnosed by doctor - None of the above | Medical conditionsUKBB000008991.14
3327BCL2L15 levelsGCST904684311.14
3328MEGF10 levelsGCST904698821.14
3329Heart failure, strictFING000006061.14
3330Functional digestive disorders | digestiveUKBB000002741.14
3331Cholesterol to total lipids in very large VLDL percentage (UKB data field 23585)GCST902696821.14
3332Free cholesterol in large HDL (UKB data field 23563)GCST902696601.14
3333MANF/PTPN6 ratioGCST903153661.14
3334Corns and callosities (PheCode 700)GCST904761961.14
3335ALCAM/MSR1 ratioGCST903132401.14
3336Whole body water mass (UKB data field 23102)GCST904681841.14
3337HMOX2/TDRKH ratioGCST903150671.14
3338SPINT1 levelsGCST904707271.14
3339Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T222ECGU0002221.14
3340SUSD1 levelsGCST904707861.14
3341Polyunsaturated fatty acids to saturated fatty acids ratioGCST905025811.14
3342aseg global volume 3rd-VentricleGCST900025991.14
3343Left ventricular end systole anterior wall thicknessGCST902785121.14
3344Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T356ECGU0003561.14
3345DSC2/SPINT1 ratioGCST903145571.14
3346Arterial stiffness indexGCST0084031.14
3347CA1/HMBS ratioGCST903135731.14
3348Cholesterol esters in very large HDLGCST905003441.13
3349Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T314ECGU0003141.13
3350Plasma X-24544 levels in chronic kidney diseaseGCST902667571.13
3351aseg global volume SupraTentorialNotVentGCST900025961.13
3352Free cholesterol in medium HDL (UKB data field 23570)GCST902696671.13
3353IDP dMRI TBSS FA Superior corona radiata RGCST900039011.13
3354IL19 levelsGCST904695681.13
3355aparc-DKTatlas lh volume insulaGCST900028931.13
3356HDL cholesterol | Blood biochemistryUKBB000003061.13
3357ITGA5/LILRA2 ratioGCST903152041.13
3358BCHE levelsGCST904684291.13
3359MASP1 levelsGCST904698631.13
3360T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 31)GCST903208501.13
3361DTI TBSS L2 Superior fronto-occipital fasciculus LGCST903845191.12
3362Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T388ECGA0003881.12
3363IDP dMRI TBSS L2 Anterior limb of internal capsule LGCST900041401.12
3364F7/F9 ratioGCST903147431.12
3365Sexual abuseGCST905518371.12
3366Acute appendicitis, with complicationsFING000000191.12
3367Prescriptions - stimulant laxative|laxativeUKBB000007021.12
3368aparc-a2009s lh volume S-calcarineGCST900029681.12
3369SNAP23 levelsGCST904706901.12
3370Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T157ECGA0001571.12
3371Triglyceride levels (UKB data field 30870)GCST904681061.12
3372CDCP1/MSR1 ratioGCST903139381.12
3373aparc-DKTatlas lh volume parstriangularisGCST900028801.11
3374COLEC12/LTBR ratioGCST903141821.11
3375PTPN1/SCAMP3 ratioGCST903157431.11
3376ATG16L1 levelsGCST904683831.11
3377IDP T1 FAST ROIs R putamenGCST900025521.11
3378IDP dMRI TBSS ICVF External capsule LGCST900043601.11
3379COL1A1 levelsGCST902407441.11
3380Gout, unspecifiedFING000005891.11
3381ANKMY2 levelsGCST904683091.11
3382Cholesteryl ester levels in HDLGCST900928231.11
3383Senile cataractFING000012901.11
3384CD40LG levelsGCST904686321.11
3385Type 2 diabetes with renal manifestations (PheCode 250.22)GCST904756701.11
3386Linoleic acid to total fatty acids percentageGCST905020231.11
3387DTI TBSS L3 Fornix cres+Stria terminalis LGCST903845631.11
3388Cervical disc disordersFING000002651.11
3389Autoimmune hepatitisGCST900185651.11
3390ALB levelsGCST900928071.11
3391aparc-pial lh area rostralmiddlefrontalGCST900031671.11
3392Treatment/medication code - amlodipine | MedicationsUKBB000008401.11
3393Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T479ECGU0004791.11
3394Cholesterol in very large VLDL (UKB data field 23491)GCST902695881.11
3395FIS1/PDGFB ratioGCST903148301.11
3396Abdominal subcutaneous adipose tissue volumeGCST900166721.11
3397TBCB levelsGCST904708131.10
3398Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T498ECGA0004981.10
3399Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T3ECGA0000031.10
3400CCL25 levelsGCST904685771.10
3401Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T206ECGA0002061.10
3402Myristoyl dihydrosphingomyelin (d18:0/14:0) levelsGCST902000491.10
3403Pre-eclampsia or poor fetal growthFING000012021.10
3404Triglycerides to Total Lipids in Small LDL percentageGCST904997401.10
3405CXCL16 levelsGCST900120591.10
3406Acetoacetate levels (UKB data field 23476)GCST902695731.10
3407SGSH levelsGCST904706151.10
3408IDP dMRI ProbtrackX ICVF ilf rGCST900043901.10
3409FIS1 levelsGCST904692401.10
3410Triglycerides to Total Lipids in Very Large VLDL percentageGCST905006921.10
3411T1 FreeSurfer DK rh MeanThickness thicknessGCST903857571.10
3412Arm fat-free mass (right) | Impedance measuresUKBB000000481.10
3413Cholesteryl esters in large HDL (UKB data field 23562)GCST902696591.09
3414CCL11 levelsGCST904685641.09
3415CirrhosisGCST903198771.09
3416Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T304ECGA0003041.09
3417CIRBP levelsGCST904687561.09
3418Total concentration of branched-chain amino acids (leucine + isoleucine + valine) (UKB data field 23464)GCST902695611.09
3419IFNAR1 levelsGCST904695121.09
3420Diacylglycerol_34:3_[M+H-H2O]1+ levelsGCST900601771.09
3421Degree of unsaturationGCST905027491.09
3422ACRBP levelsGCST904682051.09
3423ILKAP levelsGCST904696081.09
3424VASH1 levelsGCST904710261.09
3425Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T435ECGA0004351.09
3426Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T353ECGU0003531.09
3427Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T494ECGU0004941.09
3428T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 112)GCST903209311.09
3429CRIM1 levelsGCST904688631.09
3430IDP T1 FAST ROIs R hippocampusGCST900025561.09
3431Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T331ECGA0003311.09
3432aparc-a2009s rh volume S-oc-middle+LunatusGCST900030551.09
3433aseg rh intensity CaudateGCST900037831.09
3434LAP3 levelsGCST904697371.09
3435Cholesterol to Total Lipids in Very Large HDL percentageGCST905003331.09
3436T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 86)GCST903206491.09
3437GSTA3 levelsGCST904694121.08
3438ARHGAP25 levelsGCST904683531.08
3439Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T199ECGA0001991.08
3440Lysoalkylphosphatidylcholine (O-24:0) levelsGCST900254361.08
3441CDK8_CCNC levelsGCST902408251.08
3442Glomerular disorders in diseases classified elsewhereFING000005821.08
3443SBSN levelsGCST904705311.08
3444IDP dMRI TBSS L2 Corticospinal tract RGCST900041291.08
3445Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T56ECGU0000561.08
3446ACOT13 levelsGCST904682001.08
3447TBL1X levelsGCST904708151.08
3448AMBP/EFEMP1 ratioGCST903132531.08
3449CNTNAP2/DPP10 ratioGCST903141671.08
3450Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T325ECGU0003251.08
3451CD69/PLXNB3 ratioGCST903138811.08
3452DPP4 levelsGCST904690331.08
3453RHOC/TBCB ratioGCST903157741.08
3454HDL cholesterol levels (UKB data field 23406)GCST902695031.08
3455HTRA2 levelsGCST904694941.08
3456IDP dMRI ProbtrackX L3 ptr rGCST900043201.08
3457EIF4EBP1 levelsGCST904690951.08
3458PDIA4 levelsGCST904701951.08
3459Cholesterol in large HDL (UKB data field 23561)GCST902696581.08
3460CD300LG/CD93 ratioGCST903138001.07
3461HDL cholesterol levelsGCST900928221.07
3462Triglycerides in VLDLGCST905002951.07
3463CDHR2/MME ratioGCST903139631.07
3464Degree of unsaturationGCST905027361.07
3465Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T131ECGU0001311.07
3466Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T352ECGU0003521.07
3467IDP dMRI TBSS L2 Middle cerebellar peduncleGCST900041231.07
3468ATG4A levelsGCST904683841.07
3469Cholesteryl ester levels in large HDLGCST900928461.07
3470Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T324ECGU0003241.07
3471IDP dMRI TBSS L1 Retrolenticular part of internal capsule RGCST900040951.07
3472Cholesteryl Esters to Total Lipids in Small HDL percentageGCST904994061.07
3473Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T232ECGA0002321.07
3474DNAJB1/SIRT2 ratioGCST903145111.07
3475Free Cholesterol to Total Lipids in Medium HDL percentageGCST904985801.07
3476CCL17/F2R ratioGCST903136861.07
3477Leg predicted mass (right) | Impedance measuresUKBB000003971.07
3478LTBP2/MYOC ratioGCST903153371.07
3479CA2/UBAC1 ratioGCST903135831.07
3480Potatoes likingGCST900948161.06
3481Saturated fatty acids levelsGCST905026751.06
3482Bone marrow fat fraction of lumbar vertebra 3GCST906523881.06
3483TRIAP1 levelsGCST904709631.06
3484Ventricular arrhythmiaGCST900187201.06
3485CXCL17 levelsGCST904689291.06
3486TNIP1 levelsGCST904709251.06
3487Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T305ECGU0003051.06
3488SYT1 levelsGCST904707941.06
3489Concentration of large HDL particles (UKB data field 23558)GCST902696551.06
3490Cholesterol levels in large HDLGCST900928441.06
3491FGF2 levelsGCST904692241.06
3492Headaches for 3+ months | PainUKBB000003071.06
3493Total lipids in very large HDLGCST905004101.06
3494LATS1 levelsGCST904697401.06
3495APOM/ERBB3 ratioGCST903133141.06
3496aseg global volume TotalGrayGCST900025941.06
3497CD38/RELT ratioGCST903138091.06
3498CNTN5/ROBO2 ratioGCST903141661.06
3499IDP dMRI TBSS ICVF Sagittal stratum RGCST900043571.06
3500Cholesterol in large VLDL (UKB data field 23498)GCST902695951.06
3501FAM3B/GPA33 ratioGCST903147781.06
3502Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T47ECGA0000471.06
3503ARHGEF12 levelsGCST904683581.06
3504Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905009921.06
3505Chronic pain (confirmatory factor analysis Factor 18)GCST903093521.06
3506DLG4 levelsGCST904690011.06
3507IDP dMRI ProbtrackX L3 cst rGCST900043091.06
3508Body fat percentage (adjusted for testosterone and SHBG)GCST904321801.06
3509Arm fat-free mass (left) | Impedance measuresUKBB000000471.06
3510Bone marrow fat fraction of thoracic vertebra 12GCST906523841.05
3511Bone marrow fat fraction of thoracic vertebra 8GCST906523801.05
3512CLEC1B/RWDD1 ratioGCST903141021.05
3513USP8 levelsGCST904710221.05
3514PPBP levelsGCST904702891.05
3515Degree of unsaturationGCST905027521.05
3516CD84/SEMA4D ratioGCST903139171.05
3517Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T239ECGU0002391.05
3518Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T436ECGA0004361.05
3519AP3B1 levelsGCST904683251.05
3520Phosphatidylcholine-O_31:0_[M+H]1+/Phosphatidylethanolamine-O_34:0_[M+H]1+ levelsGCST900602431.05
35211-margaroyl-2-linoleoyl-GPC (17:0/18:2) metabolite levelGCST906160131.05
3522NSFL1C levelsGCST904700891.05
3523VSIR levelsGCST904710531.05
3524CDKN1A/FXN ratioGCST903139711.05
3525Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T221ECGU0002211.05
3526Triglycerides in medium VLDL (UKB data field 23508)GCST902696051.05
3527Acute osteomyelitis (PheCode 710.11)GCST904762221.05
3528Plasma 3-hydroxyhexanoate levels in chronic kidney diseaseGCST902644981.05
3529Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T439ECGA0004391.05
3530SERPINI1 levelsGCST904706021.05
3531MPI/TACC3 ratioGCST903154911.05
3532STAMBP levelsGCST904707561.04
3533Leg fat-free mass (right) | Impedance measuresUKBB000003941.04
3534SPP1 levelsGCST904707331.04
3535Open wound of foot except toe(s) alone (PheCode 871.3)GCST904762861.04
3536CHMP6 levelsGCST904687471.04
3537DFFA/FOXO1 ratioGCST903144561.04
3538Cholesteryl esters in very large VLDL (UKB data field 23492)GCST902695891.04
3539SLMAP levelsGCST904706731.04
3540Aspartate aminotransferase (AST, maximum, inv-norm transformed)GCST904751181.04
3541Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T115ECGU0001151.04
3542BACH1/CNST ratioGCST903134361.04
3543Phosphate | Blood biochemistryUKBB000006441.04
3544EFNA1/PIK3IP1 ratioGCST903145981.04
3545IDP dMRI ProbtrackX ICVF ifo lGCST900043871.04
3546Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T311ECGU0003111.04
3547DTX3 levelsGCST904690481.04
3548CD4/LILRB4 ratioGCST903138431.04
3549RIDA levelsGCST904704691.04
3550Spermatocele (PheCode 603.2)GCST904761581.04
3551Left ventricular end systole anterospetal wall thicknessGCST902785131.04
3552Endometriosis of rectovaginal septum and vaginaFING000005031.04
3553Phlebitis and thrombophlebitis (not including DVT)FING000011651.03
3554Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905009581.03
35552,3-dihydroxy-5-methylthio-4-pentenoate (dmtpa) levelsGCST902002331.03
3556Methods of admission to hospital (recoded) - Elective admission: Planned | Summary AdministrationUKBB000004621.03
3557Dihexosylceramide (d18:1/24:0) levelsGCST900253491.03
3558ITGB1/NCAM1 ratioGCST903152271.03
3559IDP dMRI TBSS ISOVF Posterior thalamic radiation LGCST900045061.03
3560Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T354ECGU0003541.03
3561COX5B/GFER ratioGCST903142001.03
3562Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T330ECGA0003301.03
3563Triglyceride levels in chylomicrons and extremely large VLDLGCST901326301.03
3564Testicular dysfunction (PheCode 257)GCST904756961.03
3565IDP dMRI TBSS ICVF Retrolenticular part of internal capsule RGCST900043471.03
3566BA-exvivo lh area BA2GCST900032081.03
3567Triglycerides in large VLDLGCST904982801.03
3568Concentration of VLDL particlesGCST905002501.03
3569FYB1 levelsGCST904692841.03
3570Endometrial cancerGCST0064641.03
3571Triglycerides to Total Lipids in Medium LDL percentageGCST904988811.03
3572CTSF/SMPDL3A ratioGCST903143161.03
3573VEGFA levelsGCST900119951.03
3574Arm predicted mass (left) | Impedance measuresUKBB000000491.03
3575Arm predicted mass (right) | Impedance measuresUKBB000000501.03
3576Phosphatidylcholine diacyl C38:4 levelsGCST902400461.02
3577High-grade serous epithelial ovarian cancerGCST902441681.02
3578VTI1A levelsGCST904710601.02
3579Free cholesterol to total lipids ratio in very large HDLGCST900930091.02
3580Cholesterol in Medium HDLGCST904984951.02
3581Concentration of large VLDL particlesGCST904982261.02
3582Peripheral artery diseaseGCST900186701.02
3583Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T437ECGA0004371.02
3584Phospholipids in very large HDLGCST905004581.02
3585APOD levelsGCST904683371.02
3586DTI TBSS MD Posterior corona radiata LGCST903845991.02
3587CERT/PRTFDC1 ratioGCST903140291.02
3588DNAJC6 levelsGCST904690171.02
3589ABO levelsGCST904681911.02
3590Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T303ECGA0003031.02
3591PLCB2 levelsGCST904702551.02
3592Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T15ECGA0000151.02
3593PTGDS levelsGCST904703681.02
3594T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 117)GCST903206801.02
3595Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T311ECGA0003111.02
3596SLPI levelsGCST904260301.02
3597Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T39ECGA0000391.01
3598SnoringGCST0097601.01
3599Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T196ECGA0001961.01
3600Right-hemisphere visual network to right-hemisphere somatomotor network white-matter structural connectivityGCST903027751.01
3601Phospholipids to Total Lipids in Very Large HDL percentageGCST905004741.01
3602EDAR/TNFSF12 ratioGCST903145911.01
3603Total lipids in HDL (UKB data field 23426)GCST902695231.01
3604CLEC1B/NSFL1C ratioGCST903140991.01
3605IDP dMRI TBSS L3 Sagittal stratum RGCST900042011.01
3606Triglycerides in small HDLGCST904995191.01
3607Fasting insulinGCST900022381.01
3608Bone marrow fat fraction of lumbar vertebra 5GCST906523901.01
3609CFH levelsGCST904687291.01
3610ACADSB levelsGCST904681951.01
3611Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T310ECGU0003101.01
3612DNAJB6 levelsGCST904690141.01
3613Volume of left accessory basal nucleusGCST904748741.01
3614Alanine aminotransferase | Blood biochemistryUKBB000000181.01
3615KIFBP levelsGCST904696831.01
3616CA4/PECAM1 ratioGCST903135861.00
3617HemoglobinGCST902786311.00
3618wg lh intensity-contrast posteriorcingulateGCST900038141.00
3619BIN2 levelsGCST904684451.00
3620Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T306ECGU0003061.00
3621Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T127ECGA0001271.00
3622IL1R2 levelsGCST904695721.00
3623DTI TBSS L2 Superior longitudinal fasciculus RGCST903845161.00
3624Alanine aminotransferase levelsGCST900259791.00
3625Medication use (calcium channel blockers)GCST900187671.00
3626Free Cholesterol to Total Lipids in Large VLDL percentageGCST904981991.00
3627Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T499ECGA0004991.00
3628CAMSAP1 levelsGCST904685351.00
3629CRADD levelsGCST904688541.00
3630UXS1 levelsGCST904710231.00
3631PRR15 levelsGCST904247901.00
3632Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T188ECGA0001881.00
3633NECTIN2/SDC1 ratioGCST903155291.00
3634wg lh intensity-contrast parstriangularisGCST900038111.00
3635T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 22)GCST903208411.00
3636Cholesterol in Large VLDLGCST904981231.00
3637Phospholipids to total lipids in very large HDL percentage (UKB data field 23629)GCST902697261.00
3638Omega-3 fatty acids levelsGCST904991450.99
3639aseg lh intensity Lateral-VentricleGCST900037640.99
3640OtosclerosisFING000011310.99
3641SIAE/SNAP29 ratioGCST903158430.99
3642CCL2/CCL7 ratioGCST903136960.99
3643PTPN1/WWP2 ratioGCST903157460.99
3644KCNA10 levelsGCST906178930.99
3645CST1 levelsGCST904688930.99
3646PNLIPRP2 levelsGCST904702740.99
3647T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 94)GCST903209130.99
3648IDP dMRI ProbtrackX L1 ifo rGCST900042590.99
3649CRKL/SERPINB1 ratioGCST903142720.99
3650Androstenediol (3beta,17beta) monosulfate (1) levelsGCST901998720.99
3651Leg fat-free mass (left) | Impedance measuresUKBB000003930.99
3652IDP dMRI TBSS L2 Cingulum cingulate gyrus LGCST900041580.99
3653Irritability | Mental healthUKBB000003800.99
3654QC SWI-to-T1 linear alignment discrepancyGCST900063520.99
3655N2-acetyl,N6,N6-dimethyllysine levelsGCST902006970.98
3656VAMP8 levelsGCST904710250.98
3657CGREF1/FAM3C ratioGCST903140320.98
3658IDP dMRI TBSS L3 Cingulum cingulate gyrus RGCST900042050.98
3659Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T178ECGU0001780.98
3660Urine glycine conjugate of C10H14O2 (1)* levels in chronic kidney diseaseGCST902652740.98
3661NECTIN4/TGFBR2 ratioGCST903155350.98
3662CACNA2D3 levelsGCST902433480.98
3663Phospholipids to total lipids ratio in very large HDLGCST900930130.98
3664HGS levelsGCST904694500.98
3665SNX18 levelsGCST904707000.98
3666Operation code - pilonidal sinus surgery (anal) | OperationsUKBB000005630.98
3667Main speciality of consultant (recoded) - Anaesthetics | Summary AdministrationUKBB000004130.98
3668T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 124)GCST903206870.98
3669Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T4ECGA0000040.98
36705,6-dihydrouridine levelsGCST901997670.98
3671aparc-pial rh area lateralorbitofrontalGCST900031850.98
3672Divergent concomitant strabismusFING000004700.98
3673SERPINB6 levelsGCST904705910.98
3674IDP dMRI TBSS L3 Cingulum cingulate gyrus LGCST900042060.98
3675SLC9A3R1 levelsGCST904706650.98
3676ARHGAP45 levelsGCST904683550.98
3677Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T438ECGA0004380.97
3678ANXA4/LACTB2 ratioGCST903132930.97
3679Cholesterol to Total Lipids in Small VLDL percentageGCST904997600.97
3680Posterior thigh muscle fat infiltration percentageGCST902673550.97
3681HDL cholesterolGCST900187360.97
3682Bone marrow fat fraction of right proximal femurGCST906523930.97
3683Ceramide (d17:1/22:0) levelsGCST900240320.97
3684IDP dMRI TBSS L1 Anterior corona radiata LGCST900040980.97
3685Gastric polypGCST900186300.97
3686aparc-DKTatlas rh area fusiformGCST900032700.97
3687Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T475ECGU0004750.97
3688T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 63)GCST903208820.97
3689Immature fraction of reticulocytesGCST900259710.97
3690Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T191ECGA0001910.97
3691HPCAL1/PMVK ratioGCST903150760.97
3692Free cholesterol levels in large HDLGCST900928480.97
3693CCL4 levelsGCST902747700.97
3694Migraine, single triptan purchase ok & required. ICD-code if available is includedFING000008240.97
3695Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T219ECGU0002190.97
3696MZT1 levelsGCST904699880.97
3697Pulse rate (UKB data field 102)GCST904681770.97
3698X-18922 levelsGCST902005780.97
3699AXIN1/MAVS ratioGCST903134140.97
3700Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T476ECGU0004760.97
3701Cholesteryl Esters in Large VLDLGCST904981540.97
3702TOP2B levelsGCST904709340.97
3703Cardiomyopathy (excluding other)FING000002510.96
3704Biliary cirrhosis, NASFING000002130.96
3705BMP4 levelsGCST904684530.96
3706Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T192ECGA0001920.96
3707GIPC3 levelsGCST904693480.96
3708Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T335ECGU0003350.96
3709wg rh intensity-contrast insulaGCST900038610.96
3710APOA levelsGCST904680610.96
3711PDLIM7/PLA2G4A ratioGCST903156370.96
3712Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T322ECGU0003220.96
3713CCN2/DKK1 ratioGCST903137100.96
3714DTI TBSS MD Anterior corona radiata LGCST903845950.96
3715CD40 levelsGCST904686330.96
3716CDHR5 levelsGCST904686800.96
3717F7 levelsGCST904691710.96
3718Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T57ECGU0000570.96
3719CASP10 levelsGCST904685420.96
3720PINLYP levelsGCST904702380.96
3721Rosacea (PheCode 695.3)GCST904761780.96
3722Feeling miserableGCST0069430.95
3723CNST levelsGCST904688010.95
3724CRTAM/PDCD1 ratioGCST903142790.95
3725Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T152ECGA0001520.95
3726Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T385ECGA0003850.95
3727Triglyceride levels (MTAG)GCST901791490.95
3728PRUNE2 levelsGCST904703490.95
3729Takes medication for congestive heart failure?GCST904752010.95
3730Alcohol frequency weekly (weighted GWA)GCST902672670.95
3731Phospholipids in small VLDLGCST904998710.95
3732Cholesteryl esters in HDL (UKB data field 23418)GCST902695150.95
3733Tryptophan levelsGCST902434030.95
3734Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905023990.95
3735Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T211ECGA0002110.95
3736OTUD7B levelsGCST904701370.95
3737Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T327ECGU0003270.95
3738Phosphatidylcholine-O_34:1_[M+H]1+/Phosphatidylcholine-P_34:0_[M+H]1+/Phosphatidylethanolamine-O_37:1_[M+H]1+ levelsGCST900602840.95
3739TMED8 levelsGCST904708850.94
3740Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T118ECGA0001180.94
3741Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T9ECGA0000090.94
3742Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T307ECGA0003070.94
3743CD20 on IgD- CD27- B cellGCST900017540.94
3744Left-hemisphere control network to right-hemisphere default mode network white-matter structural connectivityGCST903027510.94
3745Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T81ECGU0000810.94
3746Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T249ECGU0002490.94
3747IDP dMRI TBSS L3 Anterior limb of internal capsule LGCST900041880.94
3748IDP dMRI ProbtrackX L1 slf lGCST900042670.94
3749Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)FING000007560.94
3750Flat foot (PheCode 735.1)GCST904762480.94
3751Omega-6 fatty acids to total fatty acids percentageGCST905025450.94
3752Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T189ECGA0001890.94
3753Triacylglycerol_53:3_[M+NH4]1+ levelsGCST900605280.94
3754EHBP1 levelsGCST904690880.94
3755Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T180ECGU0001800.94
3756CD58/ERBB3 ratioGCST903138480.94
3757aparc-a2009s lh volume G-front-inf-TriangulGCST900029380.94
3758THBS4 levelsGCST904708550.93
3759low density lipoprotein cholesterol (LDLC, mean, inv-norm transformed)GCST904754160.93
3760ANXA4 levelsGCST904683190.93
3761Straight vs curly hairGCST0060940.93
3762CKB levelsGCST904687590.93
3763Mean volume of bilateral amygdalaGCST904748990.93
3764ALCAM/ENPP2 ratioGCST903132360.93
3765IDP dMRI TBSS ISOVF Anterior corona radiata RGCST900044990.93
3766IDP dMRI ProbtrackX L3 atr rGCST900043030.93
3767Phospholipids to Total Lipids in Small VLDL percentageGCST904998950.93
3768CLEC3B levelsGCST904687700.93
3769Total lipids in large VLDLGCST904982070.93
3770PGLS levelsGCST906189250.93
3771Diacylglycerol_44:7_[M+H-H2O]1+ levelsGCST900602400.93
3772Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T104ECGA0001040.93
3773LMNB2 levelsGCST904697820.93
3774Ratio of docosahexaenoic acid to total fatty acid levelsGCST900928170.93
3775CASP8/DDX58 ratioGCST903136510.93
3776Chronic sputum productionGCST902699020.93
3777Degree of unsaturationGCST905027480.93
3778Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T117ECGA0001170.93
3779IDP T1 FAST ROIs L pallidumGCST900025530.93
3780Fruit intake (standard GWA)GCST902672820.93
3781Triglycerides in medium HDLGCST904986670.93
3782LYPD3 levelsGCST904698280.93
3783Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST905025660.93
3784rfMRI connectivity (ICA100 edge 1099)GCST900059520.93
3785GZMA/TNFRSF8 ratioGCST903150140.93
3786Leg predicted mass (left) | Impedance measuresUKBB000003960.93
3787Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T55ECGU0000550.92
3788Concentration of large HDL particlesGCST904978280.92
3789Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T75ECGU0000750.92
3790CX3CL1/LAYN ratioGCST903143250.92
3791Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T384ECGA0003840.92
3792FUT8/RSPO1 ratioGCST903148910.92
3793rfMRI amplitudes (ICA100 node 35)GCST900046230.92
3794aparc-Desikan rh volume insulaGCST900028340.92
3795Cholesterol to Total Lipids in Medium HDL percentageGCST904985160.92
3796CTSF/NAAA ratioGCST903143140.92
3797Volume of left anterior amygdaloid areaGCST904749340.92
3798Unstable angina (intermediate coronary syndrome) | circulatory systemUKBB000008830.92
3799IDP dMRI TBSS MD Splenium of corpus callosumGCST900040310.92
3800JAM2/RGMB ratioGCST903152370.92
3801Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T116ECGA0001160.92
3802Body fat percentage | Impedance measuresUKBB000001020.92
3803Breathing problems during period of job | Employment historyUKBB000001110.92
3804CNTN2 levelsGCST904688040.92
3805CCL16 levelsGCST904685680.92
3806Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T6ECGA0000060.92
3807CALCOCO1 levelsGCST904685300.92
3808CDH3 levelsGCST904686740.92
3809IDP dMRI ProbtrackX FA cst rGCST900039340.92
3810ALB levelsGCST902695760.92
3811OsteoarthritisGCST904763830.92
3812AHSA1 levelsGCST904682620.92
3813MYCT1 levelsGCST906180460.92
3814TTR levelsGCST904709850.92
3815TIE1 levelsGCST904708630.92
3816APCS levelsGCST904683280.91
3817Prescriptions - bisoprolol | selective beta1 antagonist,beta blockerUKBB000006720.91
3818SHBG levelsGCST905033150.91
3819APOA levelsUKBB000000400.91
3820IDP T1 FAST ROIs L postcent gyrusGCST900024830.91
3821Takes medication for peripheral vascular disease?GCST904752200.91
3822BLMH levelsGCST904684470.91
3823Cholesterol to Total Lipids in Very Large HDL percentageGCST905003240.91
3824IDP T1 FAST ROIs R precentral gyrusGCST900024640.91
3825IDP dMRI TBSS MD Posterior corona radiata LGCST900040540.91
3826Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T205ECGA0002050.91
3827Intrahepatic Cholestasis of Pregnancy (ICP)  (more control exclusions)FING000006920.91
3828CDKN1A/NCK2 ratioGCST903139730.91
3829TGFBR2/TNFRSF19 ratioGCST903159170.91
3830FSHB levelsGCST904692700.91
3831FURIN levelsGCST904692770.91
3832NMT1 levelsGCST904700590.91
3833ArthropathiesFING000001070.91
3834Acetoacetate levelsGCST900928040.91
3835Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T54ECGU0000540.91
3836Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T355ECGU0003550.91
3837Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T324ECGA0003240.91
3838CCL23 levelsGCST904685750.91
3839T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 88)GCST903209070.91
3840Triglycerides in very large HDLGCST905004820.91
3841RILP levelsGCST904704710.91
3842PTPRK levelsGCST904703830.91
3843JPT2 levelsGCST904696630.91
3844Treatment speciality of consultant (recoded) - General surgery | Summary AdministrationUKBB000008340.91
3845DTI TBSS L2 Posterior thalamic radiation LGCST903845050.91
3846Triglycerides to Total Lipids in IDL percentageGCST904976760.91
3847HippSubfield lh volume CA4-bodyGCST900026830.91
3848OsteomyelitisFING000009110.91
3849Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T310ECGA0003100.91
3850BGN levelsGCST904684410.91
3851REN levelsGCST900120380.91
3852Free cholesterol in IDLGCST904975610.90
3853Crisps likingGCST900947470.90
3854CD46/THBD ratioGCST903138360.90
3855PCSK9 levelsGCST904701770.90
3856ECM1 levelsGCST904690650.90
3857Pre-eclampsiaFING000012000.90
3858Cholesterol to Total Lipids in Very Large VLDL percentageGCST905005420.90
3859SCG3 levelsGCST904705390.90
3860Vascular/heart problems diagnosed by doctor - High blood pressure | Medical conditionsUKBB000008980.90
3861X-12100--hydroxytryptophan levelsGCST902437020.90
3862Hip circumference | Body size measuresUKBB000003280.90
3863Phospholipids in HDLGCST904974370.90
3864PTPRB levelsGCST904703790.90
3865PPP1R12A/TXNDC5 ratioGCST903157140.90
3866ARHGEF1 levelsGCST904683590.90
3867Free cholesterol to total lipids in very large HDL percentage (UKB data field 23632)GCST902697290.90
3868ITGB1/TFPI ratioGCST903152310.90
3869IDP dMRI ProbtrackX L1 str rGCST900042700.90
3870RGMA/RGMB ratioGCST903157690.90
3871COLEC12/TNFRSF1A ratioGCST903141870.90
3872MAD1L1 levelsGCST904698360.90
3873Phospholipids in very large HDLGCST905004510.90
3874TAB2 levelsGCST904707960.90
3875Cholesteryl Esters to Total Lipids in Very Large HDL percentageGCST905003590.90
3876Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T99ECGA0000990.89
3877IDP dMRI TBSS L3 Superior corona radiata RGCST900041950.89
3878CASP8 levelsGCST904685480.89
3879AKT1S1 levelsGCST904682760.89
3880SH2B3/TBL1X ratioGCST903158410.89
3881Free Cholesterol to Total Lipids in Large VLDL percentageGCST904982040.89
3882Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T224ECGU0002240.89
3883EEF1D levelsGCST904690750.89
3884FGL1 levelsGCST904692350.89
3885CANT1/ROR1 ratioGCST903136200.89
3886IDP dMRI TBSS L2 Uncinate fasciculus LGCST900041680.89
3887Holdemania abundance in stoolGCST900324320.89
3888Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T112ECGA0001120.89
3889aparc-DKTatlas lh volume rostralmiddlefrontalGCST900028870.89
3890CEP170 levelsGCST904687110.89
3891Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T81ECGA0000810.89
3892Chronic lung diseases including COPD, Emphysema and BronchitisGCST904752720.89
3893Diacylglycerol (14:0_18:2) levelsGCST900247050.89
3894Phospholipids in VLDLGCST905002680.89
3895Familial combined hyperlipidemia defined by Consensus criteriaGCST901040060.89
3896Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T332ECGA0003320.89
3897T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 66)GCST903208850.89
3898NTF4 levelsGCST904700950.89
3899Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T260ECGU0002600.89
3900Aspartate aminotransferase levels (UKB data field 30650)GCST904680630.88
3901Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T119ECGA0001190.88
3902Saturated fatty acids to total fatty acids percentageGCST905021990.88
3903AXL/VCAM1 ratioGCST903134230.88
3904Volume of left central nucleusGCST904749580.88
3905Primary coxarthrosis, bilateralFING000012120.88
3906IFNGR1/IL10RB ratioGCST903151270.88
3907Nonalcoholic steatohepatitisFING000008790.88
3908SMPD1/SMPDL3A ratioGCST903158540.88
3909Cholesterol levels in very large HDLGCST905003220.88
3910Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T150ECGA0001500.88
3911Phospholipids in HDL (UKB data field 23414)GCST902695110.88
3912UROD levelsGCST904710160.88
3913Principal component-derived dietary pattern 52GCST901330560.88
3914Pulse rate, automated reading | Blood pressureUKBB000007230.88
3915BIN2/PDLIM7 ratioGCST903135090.88
3916Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T328ECGU0003280.88
3917MAP2K6/MGMT ratioGCST903153730.88
39183-(4-hydroxyphenyl)lactate levelsGCST902435750.88
3919Free Cholesterol in HDLGCST904973810.88
3920Phospholipids to Total Lipids in Very Large HDL percentageGCST905004720.88
3921TAX1BP1 levelsGCST904708080.88
3922BA-exvivo rh volume BA2GCST900028500.88
3923Ceramide (d16:1/24:0) levelsGCST900240270.88
3924LRP11 levelsGCST904697960.87
3925Idiopathic goutFING000006580.87
3926USO1 levelsGCST904710180.87
3927Ankylosing spondylitis, strict definitionFING000000900.87
3928Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T232ECGU0002320.87
3929rfMRI connectivity (ICA100 edge 1011)GCST900058640.87
3930QDPR/THOP1 ratioGCST903157570.87
3931EGLN1/PSIP1 ratioGCST903146200.87
3932Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T10ECGA0000100.87
3933CD69/NFATC1 ratioGCST903138790.87
3934C7 levelsGCST904685020.87
3935Free Cholesterol in VLDLGCST905002170.87
3936Anemia in chronic kidney disease (PheCode 285.21)GCST904757920.87
3937aparc-Desikan lh area lateraloccipitalGCST900030830.87
3938DTI autoptx L3 atr r tractGCST903851960.87
3939RAP1A levelsGCST904704250.87
3940Age started wearing glasses or contact lenses | EyesightUKBB000000170.87
3941IDP dMRI ProbtrackX L3 ptr lGCST900043190.87
3942CERT/MAX ratioGCST903140280.87
3943DTI TBSS MD External capsule RGCST903846040.87
3944Hypertensive heart and/or renal disease (PheCode 401.2)GCST904759240.87
3945PRR4 levelsGCST904703380.87
3946PLAT levelsGCST904702500.86
3947CC2D1A levelsGCST904685570.86
3948Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T262ECGA0002620.86
3949Cardiac dysrhythmias | circulatory systemUKBB000001190.86
3950IDP T1 FAST ROIs V cerebellum VIGCST900025670.86
3951Migraine (PheCode 340)GCST904758370.86
3952IDP dMRI TBSS FA Posterior limb of internal capsule RGCST900038950.86
3953Essential hypertension (PheCode 401.1)GCST904759220.86
3954aparc-a2009s rh volume G-postcentralGCST900030260.86
3955LRRC25 levelsGCST904698010.86
3956Concentration of very large HDL particlesGCST905004360.86
3957DTI TBSS MD External capsule LGCST903846050.86
3958SDC4/SMAD1 ratioGCST903158200.86
3959Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905009200.86
3960Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T65ECGA0000650.86
3961FOLR2/MSR1 ratioGCST903148660.86
3962CD4 levelsGCST904686360.86
3963Mean arterial pressure (BMI unadjusted)GCST903351680.86
3964IDP dMRI ProbtrackX ISOVF slf lGCST900045460.86
3965Concentration of large HDL particlesGCST900928510.86
3966X-21467 levelsGCST902005940.86
3967Triglycerides to Total Lipids in Very Small VLDL percentageGCST905008860.86
3968NCS1 levelsGCST904700110.86
3969Volume of right lateral nucleusGCST904750360.86
3970ICD10 N86: Erosion and ectropion of cervix uteriGCST904542170.85
3971MAX levelsGCST904698670.85
3972Cholesterol to Total Lipids in Large VLDL percentageGCST904981250.85
3973End stage renal disease (PheCode 585.32)GCST904761260.85
3974CYTL1 levelsGCST904689400.85
3975FCER2/TNFRSF9 ratioGCST903147910.85
3976Triacylglycerol_52:3_[M+NH4]1+ levelsGCST900605090.85
3977Carotid plaqueGCST0074350.85
3978Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T114ECGA0001140.85
3979Non-cancer illness code, self-reported - hypertension | Medical conditionsUKBB000005170.85
3980Total concentration of branched-chain amino acids (leucine + isoleucine + valine)GCST900929840.85
3981Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T190ECGA0001900.85
3982ASPSCR1 levelsGCST904683780.85
3983Recent inability to stop or control worrying | AnxietyUKBB000007420.85
3984Carnitine levelsGCST902434810.85
3985SF3B4 levelsGCST904706090.85
3986STK4 levelsGCST904707670.85
3987Alcoholic liver diseaseFING000000570.85
3988Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T386ECGA0003860.85
3989EREG/MPIG6B ratioGCST903147040.85
3990Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T263ECGA0002630.85
3991ROBO1 levelsGCST904704890.85
3992DBN1 levelsGCST904689500.85
3993Triglycerides in very large HDLGCST905004810.85
3994aparc-pial lh area TotalSurfaceGCST900031410.85
3995GDF2 levelsGCST904693220.85
3996Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T55ECGA0000550.85
3997SERPINE1 levelsGCST904705960.84
3998CD79B/FCRL1 ratioGCST903138990.84
3999Phospholipids to Total Lipids in Medium VLDL percentageGCST904990440.84
4000Breast cancerGCST900118040.84